Skip to main content
construction release_alert
The Scholars Team is working with OIT to resolve some issues with the Scholars search index
cancel

Ziad F. Gellad

Professor of Medicine
Medicine, Gastroenterology
Box 3913, Durham, NC 27710
508 Fulton Street, 111E GI Clinic, Durham, NC 27705

Overview


Dr. Gellad is an associate professor of medicine in the Division of Gastroenterology at Duke University Medical Center and the Chief of Gastroenterology at the Durham VA Health Care System.  His research focuses on quality of care in gastroenterology, with a particular focus on colorectal cancer screening. Dr. Gellad has also received several innovation grants to develop and implement novel information technology platforms to improve the patient and clinician experience.  He is also an active contributor to the innovation and entrepreneurship activities within Duke University and co-founder of a health technology startup in Durham, NC.

Dr. Gellad received his MD and MPH degrees from Johns Hopkins University.  He completed a residency in internal medicine and a fellowship in gastroenterology at Duke University Medical Center.   Dr. Gellad is past-chair of the Quality Measures Committee of the American Gastroenterological Association, associate editor for GI & Hepatology News and is on the Board of Editors for Clinical Gastroenterology and Hepatology.

Current Appointments & Affiliations


Professor of Medicine · 2024 - Present Medicine, Gastroenterology, Medicine
Core Faculty Member, Duke-Margolis Institute for Health Policy · 2024 - Present Duke-Margolis Institute for Health Policy, University Initiatives & Academic Support Units

Recent Publications


Real World Characterization of Chronic Pain, Success Rates and Implant Rates: Evidence from a Digital Health Platform of Patients Undergoing Spinal Cord Stimulation Evaluations.

Journal Article J Pain · December 2023 Spinal cord stimulation is an effective treatment for those experiencing chronic back and leg pain but requires a temporary evaluation period (SCSeval) before permanent implantation. We present real-world data from 7,000 patients who underwent SCSeval whil ... Full text Link to item Cite

Improving patient outcomes with a mobile digital health platform for patients undergoing transcatheter aortic valve replacement.

Journal Article J Invasive Cardiol · September 2023 PURPOSE: ManageMySurgery (MMS) is a digital health application (app) for patients undergoing surgery, including Transcatheter Aortic Valve Replacement (TAVR). Patients using MMS review procedure-specific education, view FAQs, and report patient-reported ou ... Full text Link to item Cite
View All Publications

Recent Grants


Duke Training Grant in Digestive Diseases and Nutrition

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 1988 - 2027

EFC 13794

Clinical TrialPrincipal Investigator · Awarded by Sanofi US · 2016 - 2019

DRI13940 Study

Clinical TrialPrincipal Investigator · Awarded by Sanofi-Aventis Deutschland GmbH · 2016 - 2018

View All Grants